Research programme: discodermolide analogues - Kosan Bioscience
Latest Information Update: 25 Jun 2007
At a glance
- Originator Kosan Biosciences
- Class
- Mechanism of Action Apoptosis stimulants; Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 13 Aug 2003 Preclinical trials in Cancer in USA (unspecified route)